1-A/A LIVE 0002131824 XXXXXXXX 024-12817 GOA Therapeutics Corp DE 2024 0002131824 2834 33-1382396 4 6 515 North Flagler Drive Suite 350 West Palm Beach FL 33401 561-462-2626 Andrew Altschuler Other 7057212.00 0.00 0.00 0.00 7060392.00 566929.00 0.00 606850.00 6453542.00 7060392.00 0.00 0.00 0.00 -2408693.00 0.00 0.00 Alice.CPA LLC Common Stock 65370588 000000000 NA Series Seed-1 Preferred Stock 310056 000000000 NA Series Seed-2 Preferred Stock 404332 000000000 NA Series Seed-3 Preferred Stock 25125 000000000 NA Series Seed-4 Preferred Stock 12434816 000000000 NA Series Seed-5 Preferred Stock 12434816 000000000 NA Series Seed Preferred Stock 3307032 000000000 NA Series Seed-6 Preferred Stock 2887287 000000000 NA Series Seed-7 Preferred Stock 2390448 000000000 NA Series Seed-8 Preferred Stock 619206 000000000 NA NA 0 000000000 NA true true Tier2 Audited Equity (common or preferred stock) Y N N Y N Y 5000000 65370588 15.0000 67500000.00 7500000.00 0.00 0.00 75000000.00 DealMaker Securities LLC 1348500.00 DealMaker Securities LLC 2868750.00 None 0.00 Alice.CPA 5070.00 Ellenoff Grossman & Schole LLP 180000.00 None 0.00 Ellenoff Grossman & Schole LLP 20000.00 000315324 51827680.00 Equals aggregate offering price attributable to issuer's securities (see above), minus anticipated fees (see above), minus $11,250,000 attributable to the issuance of 750,000 Bonus Shares. Excludes additional issuer expenses disclosed in Part II. true AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PR A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PR A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 GOA Therapeutics Corporation Common (CS) 1,083,876; Series Seed-6 (PS6) 2,887,287; Series Seed-7 Preferred (PS7) 2,390,448; Series Seed-8 (PS8) 619,206; Common Stock Warrants (CSW) 6,402,239; Nonstatutory Stock Options (NSO) 18,202,000; Restricted Stock (RS) 45,00 31630056 0 $12,439,117.78 (equals sum of CS $1,591,867.78; PS6 $3,204,900; PS7 $4,422,350; PS8 $3,220,000; CSW $0; NSO $0; RS $0) All such issuances under Section 4(a)(2) (limited number of accredited investors identified through pre-existing relationships, no public solicitation), or Rule 701 (employees, consultants pursuant to written plan, contracts)